We have posted before about helminthic therapy – worms that can modulate the immune system and prevent it from attacking the body’s own tissues and organs.
Well, the time has come for mid stage trials on this therapy. Currently, 220 people with Crohn’s Disease in the US are being enrolled on a mid stage trial and in Europe a further mid stage trial is being started.
The drug is called Trichuris Suis Ova (TSO) and consists of thousands of microscopic parasite eggs, suspended in saline solution – the drug is swallowed just like a tablet. The parasites are killed off in our stomachs, but the hypothesis is that, before they die off, they are able to modulate our immune systems.
If these trials go well, we are not too far off from having this new drug available on the market.
Read the full story at: